Cargando…
A Novel Cell-based Luciferase Reporter Platform for the Development and Characterization of T-Cell Redirecting Therapies and Vaccine Development
T-cell immunotherapies are promising strategies to generate T-cell responses towards tumor-derived or pathogen-derived antigens. Adoptive transfer of T cells genetically modified to express antigen receptor transgenes has shown promise for the treatment of cancer. However, the development of T-cell...
Autores principales: | Grailer, Jamison, Cheng, Zhijie Jey, Hartnett, Jim, Slater, Michael, Fan, Frank, Cong, Mei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9988225/ https://www.ncbi.nlm.nih.gov/pubmed/36809225 http://dx.doi.org/10.1097/CJI.0000000000000453 |
Ejemplares similares
-
Construction of a replication-competent hepatitis B virus vector carrying secreted luciferase transgene and establishment of new hepatitis B virus replication and expression cell lines
por: Ruan, Jie, et al.
Publicado: (2019) -
Identification of tumor antigens and immune subtypes of hepatocellular carcinoma for mRNA vaccine development
por: Lu, Tai-Liang, et al.
Publicado: (2023) -
Na(+)/HCO(3)(-) cotransporter is expressed on β and α cells during rat pancreatic development
por: Cao, Li-Hua, et al.
Publicado: (2016) -
Development of Engineered CAR T Cells Targeting Tumor-Associated Glycoforms of MUC1 for the Treatment of Intrahepatic Cholangiocarcinoma
por: Mao, Li, et al.
Publicado: (2023) -
Single cell RNA sequencing reveals mesenchymal heterogeneity and critical functions of Cd271 in tooth development
por: Zhang, Yan-Yan, et al.
Publicado: (2023)